USD 0.0
(-99.8%)
Breakdown | 2022 | 2021 | 2020 | 2019 | 2016 | 2015 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | 1.04 Billion | 1.89 Billion |
Cost of Revenue | - | - | - | - | 1.04 Billion | 1.9 Billion |
Gross Profit | - | - | - | - | 1.21 Million | -4.68 Million |
Operating Expenses | - | - | - | - | 9.46 Million | 5.17 Million |
Selling, General and Administrative Expenses | - | - | - | - | 7.25 Million | 5.17 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | - | - | - | - | 1.05 Billion | 1.9 Billion |
Operating Income | - | - | - | - | -29.52 Million | -9.18 Million |
Interest Expense | - | - | - | - | 3.09 Million | 601 Thousand |
Income Tax Expense | - | - | - | - | -6.74 Million | -2.33 Million |
Earnings before Tax | - | - | - | - | -31.14 Million | -9.36 Million |
Net Income | - | - | - | - | -20.7 Million | -7.32 Million |
Earnings Per Share Basic | - | - | - | - | -0.09 | -0.04 |
Earnings Per Share Diluted | - | - | - | - | -0.09 | -0.04 |
Weighted Average Shares Outstanding | - | - | - | - | 241.67 Million | 189.04 Million |
Weighted Average Shares Outstanding (Diluted) | - | - | - | - | 241.67 Million | 189.04 Million |
Gross Margin | - | - | - | - | 0.00 | -0.00 |
EBIT Margin | - | - | - | - | -0.00 | -0.00 |
Profit Margin | - | - | - | - | -0.02 | -0.00 |
EBITDA | - | - | - | - | -4.56 Million | -9 Million |
Earnings Before Tax Margin | - | - | - | - | -0.03 | -0.00 |
Breakdown | 2022 FY | 2021 FY | 2020 FY | 2019 FY | 2016 FY | 2015 FY |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | 1.04 Billion | 1.89 Billion |
Cost of Revenue | - | - | - | - | 1.04 Billion | 1.9 Billion |
Gross Profit | - | - | - | - | 1.21 Million | -4.68 Million |
Operating Expenses | - | - | - | - | 9.46 Million | 5.17 Million |
Selling, General and Administrative Expenses | - | - | - | - | - | - |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | - | - | - | - | 1.05 Billion | 1.9 Billion |
Operating Income | - | - | - | - | -29.52 Million | -9.18 Million |
Interest Expense | - | - | - | - | 3.09 Million | 601 Thousand |
Income Tax Expense | - | - | - | - | -6.74 Million | -2.33 Million |
Earnings before Tax | - | - | - | - | -31.14 Million | -9.36 Million |
Net Income | - | - | - | - | -20.7 Million | -7.32 Million |
Earnings Per Share Basic | - | - | - | - | - | - |
Earnings Per Share Diluted | - | - | - | - | - | - |
Weighted Average Shares Outstanding | - | - | - | - | 241.67 Million | 189.04 Million |
Weighted Average Shares Outstanding (Diluted) | - | - | - | - | 241.67 Million | 189.04 Million |
Gross Margin | - | - | - | - | 0.00 | -0.00 |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | -0.02 | -0.00 |
EBITDA | - | - | - | - | - | - |
Earnings Before Tax Margin | - | - | - | - | -0.03 | -0.00 |
GUJCONT
7685
4689
IONAF
GSK
DHANUKA